tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

STXS Stock Latest News

Promising Prospects for Stereotaxis’ MAGiC Catheter: A Buy Rating Reinforced by Strong Efficacy and Safety
RatingsPromising Prospects for Stereotaxis’ MAGiC Catheter: A Buy Rating Reinforced by Strong Efficacy and Safety
9d ago
STXS
Stereotaxis announces publication of clinical results using MAGiC catheter
PremiumThe Fly
Stereotaxis announces publication of clinical results using MAGiC catheter
10d ago
STXS
Stereotaxis Holds 2025 Annual Shareholders Meeting
PremiumCompany Announcements
Stereotaxis Holds 2025 Annual Shareholders Meeting
2M ago
8K
STXS
Stereotaxis Balances Growth and Challenges in Earnings Call
PremiumCompany Announcements
Stereotaxis Balances Growth and Challenges in Earnings Call
2M ago
STXS
Stereotaxis Reports Q1 2025 Financial Results
PremiumCompany Announcements
Stereotaxis Reports Q1 2025 Financial Results
2M ago
STXS
Stereotaxis: Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
PremiumRatingsStereotaxis: Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
2M ago
STXS
Stereotaxis reiterates expectation of double-digit revenue growth for FY25
Premium
The Fly
Stereotaxis reiterates expectation of double-digit revenue growth for FY25
2M ago
STXS
Stereotaxis reports Q1 EPS (7c), consensus (7c)
Premium
The Fly
Stereotaxis reports Q1 EPS (7c), consensus (7c)
2M ago
STXS
Stereotaxis (STXS) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Stereotaxis (STXS) Q1 Earnings Cheat Sheet
2M ago
STXS
Stereotaxis to feature first-ever live demo of GenesisX Robotic System
PremiumThe Fly
Stereotaxis to feature first-ever live demo of GenesisX Robotic System
3M ago
STXS
Stereotaxis management to meet virtually with Lake Street
PremiumThe Fly
Stereotaxis management to meet virtually with Lake Street
3M ago
STXS
Strategic Advancements Propel Stereotaxis: Buy Rating Affirmed Following NVIDIA Partnership
PremiumRatings
Strategic Advancements Propel Stereotaxis: Buy Rating Affirmed Following NVIDIA Partnership
4M ago
STXS
Stereotaxis says Nvidia highlighted technology at NVIDIA GTC
PremiumThe FlyStereotaxis says Nvidia highlighted technology at NVIDIA GTC
4M ago
NVDA
STXS
Stereotaxis: Buy Rating Affirmed on Strong Financials and Promising Growth Outlook
Premium
Ratings
Stereotaxis: Buy Rating Affirmed on Strong Financials and Promising Growth Outlook
4M ago
STXS
Stereotaxis Reports Strong Revenue Growth and Strategic Milestones
Premium
Company Announcements
Stereotaxis Reports Strong Revenue Growth and Strategic Milestones
4M ago
STXS
Stereotaxis Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Stereotaxis Earnings Call: Growth Amid Challenges
4M ago
STXS
Stereotaxis sees double digit revenue growth for FY25
PremiumThe Fly
Stereotaxis sees double digit revenue growth for FY25
4M ago
STXS
Correction: Stereotaxis did not guide to FY25 revenue of $3.3B-$3.45B
PremiumThe Fly
Correction: Stereotaxis did not guide to FY25 revenue of $3.3B-$3.45B
4M ago
STXS
Stereotaxis submits EMAGIN catheter for regulatory clearance
PremiumThe Fly
Stereotaxis submits EMAGIN catheter for regulatory clearance
4M ago
STXS
Stereotaxis announces FDA regulatory submission for MAGiC Sweep catheter
PremiumThe FlyStereotaxis announces FDA regulatory submission for MAGiC Sweep catheter
4M ago
STXS
Stereotaxis reports Q4 EPS (9c), consensus (6c)
Premium
The Fly
Stereotaxis reports Q4 EPS (9c), consensus (6c)
4M ago
STXS
Stereotaxis sees FY25 revenue $3.3B-$3.45B, consensus $3.39B
Premium
The Fly
Stereotaxis sees FY25 revenue $3.3B-$3.45B, consensus $3.39B
4M ago
STXS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >